Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
CBRE Group Signs $610M M&A Deal with Onnec Group Limited
CBRE Group, Inc. has entered into a definitive agreement to acquire Onnec Group Limited, a London-based provider of data center infrastructure services, for an initial cash price of £460 million (approximately $610 million). The deal includes a multi-year earnout of up to £300 million ($400 million) and is intended to expand CBRE's global critical infrastructure capabilities across Europe and Asia Pacific.
Treasure Global Inc entered into subscription agreements with three investors, including its Acting CEO and CFO, to raise an aggregate of $1.2 million through the sale of common stock. The investment will be made in two equal tranches of $200,000 per investor, with the share price set at the greater of $0.45 or the closing price prior to completion. The offerings are being conducted under Regulation S and involve restricted securities subject to a six-month distribution compliance period.
Value
$1.2M
Counterparty
Chan Meng Chun, Pusparajan a/l Vadiveloo and Teo Chong Chan
SHF Holdings received a formal 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company met all other listing standards and has notified Nasdaq of its intent to cure the deficiency, potentially through a reverse stock split if necessary.
Indaptus Therapeutics completed a private placement of 20,338,974 shares of common stock for aggregate gross proceeds of approximately $24.0 million. The closing follows a previously announced stock purchase agreement dated September 8, 2026, and a subsequent extension of the outside closing date to October 16, 2026.
Conexeu Sciences Inc. closed a private placement of 1,333,333 units at $3.00 per unit for gross proceeds of approximately $4.0 million. Each unit consists of one share of common stock and one warrant to purchase an additional share at $3.00. The company intends to use the proceeds for working capital and general corporate purposes.
Lifecore Biomedical, Inc. \De\ M&A Deal with Lifecore Inc.
Lifecore Biomedical established November 4, 2026, as the record date for a special meeting of stockholders to vote on its previously announced merger agreement with Lifecore Inc. and Hazel Merger Sub, Inc. The company will file a proxy statement to solicit shareholder approval for the adoption of the merger agreement.
PURE Bioscience completed a private placement financing raising $555,000 through the issuance of 10,183,486 shares of common stock. The investment was made by board member Tom Y. Lee and his affiliates at a price of $0.0545 per share, with proceeds intended for research, development, and general working capital.
Blue Owl Real Estate Net Lease Trust Capital Raise of $31M
Blue Owl Real Estate Net Lease Trust sold 2,883,572 Class I common shares to feeder vehicles for gross proceeds of approximately $31.0 million. The shares were priced based on the September 30, 2026 net asset value (NAV) of $10.7668 per Class I share. The company also reported a total portfolio fair value of approximately $15.6 billion across 4,097 properties.
Bluerock Homes Trust completed the disposition of 31 single-family residential units within its ILE portfolio between January 1 and October 14, 2026. The units were sold to unaffiliated third parties for an aggregate sales price of approximately $6.6 million, resulting in net proceeds of approximately $2.0 million after debt paydown.
First Tracks Biotherapeutics, Inc. closed a private placement of 6,106,870 shares of common stock on October 19, 2026. In connection with the closing, the company entered into a registration rights agreement requiring it to file a resale registration statement for the investors within 30 days.
Marwynn Holdings M&A Deal with Zhituo Software Co., Limited
Marwynn Holdings acquired the proprietary Phase 1 core platform of the Marwynn Group Operating Platform from Zhituo Software Co., Limited. As consideration, the company agreed to issue 4,000,000 shares of common stock, which will serve as the permanent core architecture for managing the company and its subsidiaries. The agreement includes the transfer of all worldwide intellectual property rights, source code, and technical documentation.
North Haven Net REIT sold an aggregate of 442,000 shares across multiple classes (Class I, F-I, E, and L-I) for total consideration of approximately $9.25 million. The shares were sold to a feeder vehicle and other investors based on the company's net asset value per share as of September 30, 2026.
Pluri Inc. entered into a Securities Purchase Agreement with its largest shareholder, Chutzpah Holdings LP, to issue 833,334 common shares and warrants to purchase an additional 833,334 shares. The $1.25 million aggregate purchase price was satisfied by an advance payment previously received by the company in June 2026. The shares were priced at $1.50 per share, with the warrants carrying an exercise price of $1.65.
Dorchester Minerals M&A Deal with Hillside Exploration Assets, LLC
Dorchester Minerals, L.P. entered into a definitive agreement to acquire approximately 4,300 net royalty acres in the Williston Basin from Hillside Exploration Assets, LLC. The acquisition is structured as a contribution and exchange where the seller will receive 1,250,000 common units of DMLP. The deal is expected to close on October 30, 2026, and includes a cash adjustment for receipts attributed to the properties since July 1, 2026.
Hines Private Wealth Solutions completed its largest Delaware Statutory Trust (DST) offering, HREX 9 DST, raising approximately $591 million from qualified investors. The offering consists of interests in two multifamily properties, Gables Station in Florida and Left Bank in Illinois, which were sourced from Hines Global Income Trust, Inc.
ClimateRock and GreenRock Corp have amended their definitive merger agreement to extend the deal's outside closing date from May 2, 2025, to March 31, 2027. The amendment also removes the acquisition of TEP Renewables Limited as a closing condition and eliminates the earnout escrow provision.
DataMeds AI, Inc. received formal notification from Nasdaq on October 19, 2026, confirming that the company has regained compliance with the $2.5 million minimum stockholders' equity requirement for continued listing. The company had previously been in deficiency since April 2026 and had also recently regained compliance with the minimum bid-price requirement in June 2026.
Salesforce has entered into a definitive agreement to acquire customer engagement platform Braze for approximately $5.66 billion in enterprise value. Braze shareholders will receive $47.50 per share in cash, and the acquisition is intended to strengthen Salesforce Marketing Cloud's real-time B2C engagement and AI decisioning capabilities.
Value
$5.66B
Counterparty
Braze, Inc.
“Every interaction is an opportunity to wow your customers. Most of that wow comes from knowing your customer, and responding at just the right moment. Braze was built to turn live customer behavior into personalized engagement at scale. Bringing that capability together with Salesforce Marketing Cloud, CRM, and Data 360 will deliver that wow moment in every customer interaction.”
Patrick Stokes, President, Applications and Marketing, Salesforce
“Braze was built on the conviction that marketers and their creativity are a brand’s ultimate competitive advantage. This past year we shipped at the fastest pace in our history, and BrazeAI is helping marketers get their best ideas live faster. Salesforce shares our commitment to marketers, and we’ll continue building as Braze and investing in the Braze community of customers and partners who built this company with us.”
Braze, Inc. has entered into a definitive agreement to be acquired by Salesforce, Inc. for $47.50 per share in cash. Upon completion of the merger, Braze will become a wholly owned subsidiary of Salesforce and its Class A common stock will be delisted from the Nasdaq Stock Market.
Strive, Inc. closed an upsized initial public offering of 7,000,000 shares of its 15.00% Series A Perpetual SATS Preferred Stock at a price of $90 per share, generating $630 million in gross proceeds. The new security is expected to trade on the Nasdaq Global Market under the ticker symbol 'SATS' and features a 15% annual dividend on a $100 stated amount.
Value
$630M
Term
perpetual
“The successful, upsized IPO of SATS marks a critical milestone in our strategy to maximize long-term total returns for our common equity investors. We believe maintaining a high Amplification Ratio is the most important driver of our ability to outperform Bitcoin over time. SATS provides an additional tool to achieve that objective while simultaneously strengthening SATA’s credit profile by adding junior capital beneath it.”
Matt Cole, Chairman and CEO of Strive
“SATS represents the next evolution of our commitment to developing products tailored to the distinct needs of investors, introducing a fixed-rate perpetual security to our offerings. By expanding our range of highly liquid securities, we are more precisely aligning each product with the objectives of the investors it serves.”
Dime Commercial Bancshares Signs $58M M&A Deal with ES Bancshares, Inc.
Dime Commercial Bancshares has agreed to acquire ES Bancshares, Inc. in a cash and stock transaction valued at approximately $58 million. ES Bancshares shareholders will receive a combination of $30 million in aggregate cash and 720,000 shares of Dime common stock, representing a value of $8.39 per share based on recent trading prices. Following the merger, Empire State Bank will be merged into Dime Commercial Bank.
Nu-Med Plus, Inc. entered into subscription agreements with two accredited investors for the private placement of 171,232 shares of Series A Preferred Stock, raising $450,000. The company also issued 50,000 shares of Series A Preferred Stock to a consultant as compensation for services rendered.
Beazer Homes USA M&A Deal with Dream Finders Homes, Inc.
Beazer Homes USA, Inc. completed its merger with a subsidiary of Dream Finders Homes, Inc., with Beazer surviving as a wholly owned subsidiary of Dream Finders. Shareholders of Beazer are entitled to receive $33.50 in cash per share. In connection with the closing, Beazer's existing credit agreement was terminated and its $350 million 7.250% Senior Notes due 2029 were redeemed.
Freenome launched its SimpleScreen Lung test, a blood-based screening tool for adults aged 50-80 with a significant smoking history. The company also introduced a first-of-its-kind offering that allows eligible patients to be screened for both lung and colorectal cancer (CRC) through a single blood draw using two independently validated tests.
Bold Eagle Acquisition M&A Deal with REDL Intermediate Holdings, LLC
Bold Eagle Acquisition Corp. and REDLattice announced the confidential submission of a draft Form S-4 registration statement to the SEC regarding their previously announced business combination. The transaction is expected to result in REDLattice becoming a publicly traded company on Nasdaq under the ticker symbol 'REDL'.
Myriad Genetics Divestiture to Laboratory Corporation of America for $210M
Myriad Genetics has entered into a definitive agreement to sell its prenatal health testing business, including the Foresight, Prequel, and SneakPeek tests, to Labcorp for $210 million in cash. The divestiture is part of a strategic review to focus on the company's cancer care continuum and is expected to close by early 2027.
Arcus Biosciences presented new data from its ARC-20 platform study evaluating casdatifan in various treatment lines for clear cell renal cell carcinoma (ccRCC). Key results included a 50% confirmed objective response rate (cORR) for the first-line casdatifan plus zimberelimab combination and a 14.5-month median progression-free survival for the second-line combination with cabozantinib.
Kinetic Seas announced the commercial availability of three foundational AI software platforms: MaluDB, MaluOS, and MaluMail. These products provide enterprise infrastructure for building and deploying scalable agentic and generative AI applications under a dual open-source and enterprise subscription model.
Mount Logan Capital Signs $4.6M M&A Deal with Alternative Fund Advisors, LLC
Mount Logan Management, LLC, a subsidiary of Mount Logan Capital Inc., entered into a definitive agreement to acquire the management rights and related assets of the AFA Asset Based Lending Fund (AMCLX) from Alternative Fund Advisors, LLC. Mount Logan will pay up to $4.6 million in cash and deferred installments, plus 40% of management and incentive fees for five years, to succeed AFA as the fund's investment adviser.
Value
$4.6M
Counterparty
Alternative Fund Advisors, LLC
Term
5 years
“This is a significant milestone in the build-out of Mount Logan's evergreen credit platform and reflects our continued discipline in acquiring permanent and semi-permanent capital vehicles. The Fund broadens MLM's core products, extends our distribution reach in the private wealth channel, and is highly complementary to our Opportunistic Credit Interval Fund. It also provides a differentiated, institutionally managed asset-based lending strategy that leverages the credit sourcing and underwriting capabilities of the broader Mount Logan and BC Partners Credit platform.”
XWELL, Inc. received a deficiency notice from Nasdaq on October 7, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 calendar days, or until April 5, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. XWELL is monitoring the situation and considering options, including a potential reverse stock split, to address the deficiency.